Perrigo reported $0.43 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.43 0.33 0.60 May/06
FY2025Q4 Dec/2025 0.77 0.79 0.36 Feb/26
FY2025Q3 Sep/2025 0.80 0.76 0.81 Nov/05
FY2025Q2 Jun/2025 0.57 0.59 0.53 Aug/06
FY2025Q1 Mar/2025 0.60 0.48 0.29 May/07




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Abbott USD 1.15 0.35 Mar/2026
Bayer EUR 2.71 2.09 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Corcept Therapeutics USD -0.3 0.5 Mar/2026
Dr.Reddys Laboratories INR 5.8 8.72 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Nestle CHF 2.08 0.01 Dec/2025
Pacira USD 0.6 0.54 Mar/2026
Perrigo USD 0.43 0.34 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 1.23 0.09 Mar/2026
Reckitt Benckiser GBP 1.84 0.43 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026
Supernus Pharmaceuticals USD 0.6 0.67 Mar/2026
Teva Pharmaceutical Industries USD 1.57 1.41 Mar/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026
Zoetis USD 1.53 0.05 Mar/2026